This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

GSK 239512

GlaxoSmithKline plc

Drug Names(s): GSK239512

Description: GSK 239512 is a histamine H3 antagonist. Histamine H3 receptors are expressed in the central nervous system and, to a lesser extent, the peripheral nervous system. They are located presynaptically on nerve cells and their activation inhibits the release of histamine and other neurotransmitters (depending on the nerve cell), such as GABA, acetylcholine, noradrenaline, and serotonin. They have been implicated in cognition, as well as other functions.

GSK 239512 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug